AHCO Stock Overview
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$17.35|
|52 Week High||US$30.33|
|52 Week Low||US$11.40|
|1 Month Change||20.82%|
|3 Month Change||11.50%|
|1 Year Change||-33.32%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||80.73%|
Recent News & Updates
AdaptHealth: Strongest Home DME Distributor, But Industry Outlook Weak
AHCO distributes home medical supplies and equipment and is a major beneficiary of the pandemic. As with most beneficiaries, growth has stalled and uncertainty about the future is causing the valuations to plummet. While growth and profitability are above average, debt is now in-line with peers and may cause a reversion to the norm. For those interested, I am sure beginning to accumulate shares now may pay off over the years, but I will remain neutral.
|AHCO||US Healthcare||US Market|
Return vs Industry: AHCO underperformed the US Healthcare industry which returned 3.5% over the past year.
Return vs Market: AHCO underperformed the US Market which returned -12.3% over the past year.
|AHCO Average Weekly Movement||12.6%|
|Healthcare Industry Average Movement||10.5%|
|Market Average Movement||7.8%|
|10% most volatile stocks in US Market||16.9%|
|10% least volatile stocks in US Market||2.9%|
Stable Share Price: AHCO is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: AHCO's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors.
AdaptHealth Fundamentals Summary
|AHCO fundamental statistics|
Is AHCO overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|AHCO income statement (TTM)|
|Cost of Revenue||US$2.13b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||1.37|
|Net Profit Margin||6.84%|
How did AHCO perform over the long term?See historical performance and comparison
Is AdaptHealth undervalued compared to its fair value and its price relative to the market?
Valuation Score 6/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: AHCO ($17.35) is trading below our estimate of fair value ($44)
Significantly Below Fair Value: AHCO is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: AHCO is good value based on its Price-To-Earnings Ratio (12.7x) compared to the US Healthcare industry average (18.7x).
PE vs Market: AHCO is good value based on its Price-To-Earnings Ratio (12.7x) compared to the US market (15.1x).
Price to Earnings Growth Ratio
PEG Ratio: AHCO is good value based on its PEG Ratio (0.6x)
Price to Book Ratio
PB vs Industry: AHCO is good value based on its Price-To-Book Ratio (1.1x) compared to the US Healthcare industry average (2.5x).
How is AdaptHealth forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
Future Growth Score4/6
Future Growth Score 4/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AHCO's forecast earnings growth (22.2% per year) is above the savings rate (1.9%).
Earnings vs Market: AHCO's earnings (22.2% per year) are forecast to grow faster than the US market (12.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AHCO's revenue (11.1% per year) is forecast to grow faster than the US market (7.8% per year).
High Growth Revenue: AHCO's revenue (11.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AHCO's Return on Equity is forecast to be low in 3 years time (9.8%).
How has AdaptHealth performed over the past 5 years?
Past Performance Score3/6
Past Performance Score 3/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AHCO has high quality earnings.
Growing Profit Margin: AHCO became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: AHCO has become profitable over the past 5 years, growing earnings by 18.8% per year.
Accelerating Growth: AHCO has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: AHCO has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (9.6%).
Return on Equity
High ROE: AHCO's Return on Equity (9.6%) is considered low.
How is AdaptHealth's financial position?
Financial Health Score1/6
Financial Health Score 1/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: AHCO's short term assets ($615.0M) exceed its short term liabilities ($443.6M).
Long Term Liabilities: AHCO's short term assets ($615.0M) do not cover its long term liabilities ($2.6B).
Debt to Equity History and Analysis
Debt Level: AHCO's net debt to equity ratio (98.2%) is considered high.
Reducing Debt: Insufficient data to determine if AHCO's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: AHCO's debt is not well covered by operating cash flow (14.7%).
Interest Coverage: AHCO's interest payments on its debt are not well covered by EBIT (2.9x coverage).
What is AdaptHealth current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AHCO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AHCO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AHCO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AHCO's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as AHCO has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Steve Griggs (63 yo)
Mr. Stephen P. Griggs, also known as Steve, serves as a Member of Growth Fund Advisory Board at SV Health Investors, LLC He has been Chief Executive Officer at AdaptHealth Corp. since June 14, 2021 and its...
CEO Compensation Analysis
Compensation vs Market: Steve's total compensation ($USD3.98M) is about average for companies of similar size in the US market ($USD5.43M).
Compensation vs Earnings: Insufficient data to compare Steve's compensation with company performance.
Experienced Management: AHCO's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Experienced Board: AHCO's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: AHCO insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.9%.
AdaptHealth Corp.'s employee growth, exchange listings and data sources
- Name: AdaptHealth Corp.
- Ticker: AHCO
- Exchange: NasdaqCM
- Founded: NaN
- Industry: Health Care Distributors
- Sector: Healthcare
- Implied Market Cap: US$2.361b
- Shares outstanding: 134.29m
- Website: https://adapthealth.com
Number of Employees
- AdaptHealth Corp.
- 220 West Germantown Pike
- Suite 250
- Plymouth Meeting
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/24 00:00|
|End of Day Share Price||2022/05/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.